Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Icu Medical (ICUI) EBIT (2016 - 2025)

Icu Medical's EBIT history spans 17 years, with the latest figure at $5.6 million for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 85.05% year-over-year to $5.6 million, compared with a TTM value of $42.8 million through Dec 2025, changed 0.31%, and an annual FY2025 reading of $42.8 million, changed 0.31% over the prior year.
  • EBIT for Q4 2025 was $5.6 million at Icu Medical, down from $13.7 million in the prior quarter.
  • The five-year high for EBIT was $38.4 million in Q3 2021, with the low at -$42.2 million in Q1 2022.
  • Average EBIT over 5 years is $9.4 million, with a median of $8.8 million recorded in 2023.
  • Biggest YoY gain for EBIT was 5850.0% in 2023; the steepest drop was 5387.84% in 2023.
  • Tracing ICUI's EBIT over 5 years: stood at $23.8 million in 2021, then crashed by 100.93% to -$222000.0 in 2022, then plummeted by 5387.84% to -$12.2 million in 2023, then skyrocketed by 409.37% to $37.7 million in 2024, then plummeted by 85.05% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's EBIT are $5.6 million (Q4 2025), $13.7 million (Q3 2025), and $10.6 million (Q2 2025).